A detailed history of Claro Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Claro Advisors LLC holds 3,579 shares of BDX stock, worth $795,933. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,579
Previous 60,312 94.07%
Holding current value
$795,933
Previous $14.5 Million 94.07%
% of portfolio
0.12%
Previous 1.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$221.47 - $242.41 $12.6 Million - $13.8 Million
-56,733 Reduced 94.07%
3,579 $862,000
Q3 2024

Oct 17, 2024

BUY
$221.47 - $242.41 $12.7 Million - $13.9 Million
57,511 Added 2053.23%
60,312 $14.5 Million
Q2 2024

Jul 31, 2024

SELL
$225.07 - $246.17 $11,478 - $12,554
-51 Reduced 1.79%
2,801 $654,000
Q1 2024

Apr 18, 2024

BUY
$233.45 - $247.73 $139,369 - $147,894
597 Added 26.47%
2,852 $705,000
Q4 2023

Jan 22, 2024

SELL
$232.24 - $267.23 $119,603 - $137,623
-515 Reduced 18.59%
2,255 $549,000
Q3 2023

Oct 10, 2023

SELL
$254.9 - $283.59 $29,823 - $33,180
-117 Reduced 4.05%
2,770 $716,000
Q2 2023

Aug 08, 2023

BUY
$238.39 - $265.32 $168,780 - $187,846
708 Added 32.49%
2,887 $762,000
Q1 2023

Apr 17, 2023

BUY
$229.71 - $259.35 $72,588 - $81,954
316 Added 16.96%
2,179 $539,000
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $109,363 - $128,711
501 Added 36.78%
1,863 $473,000
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $116,665 - $136,883
497 Added 57.46%
1,362 $336,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $199,019 - $217,063
865 New
865 $218,000
Q1 2019

May 10, 2019

SELL
$206.05 - $248.17 $120,745 - $145,427
-586 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $119,971 - $151,146
586 New
586 $153,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.